Safety Study of Allogeneic Mesenchymal Precursor Cell Infusion in Myocardial Infarction

PHASE2CompletedINTERVENTIONAL

Enrollment

106

Participants

Timeline

Start Date

March 11, 2013

Primary Completion Date

April 6, 2021

Study Completion Date

April 6, 2021

Conditions

Acute Myocardial Infarction

Interventions

OTHER

Placebo

Matching placebo solution for infusion.

BIOLOGICAL

Mesenchymal Precursor Cells (MPC) 12.5 M

MPC 12.5 M solution for infusion.

BIOLOGICAL

Mesenchymal Precursor Cells (MPC) 25 M

MPC 25 M solution for infusion.